[ad_1]
Inoculation plan from February to March of next year
Jung Eun-kyung, head of the Central Defense Countermeasures Headquarters, is giving a briefing on the current status of the outbreak in Korea and plans to introduce a vaccine.[이미지출처=연합뉴스]
In a regular briefing on the 28th, Jung Eun-kyung, head of the Central Defense Countermeasures Headquarters, said: “The government plans to make vaccination available immediately from February to March next year when the vaccine is provided to Korea”. “We are making high-risk groups living in group facilities like nursing homes and nursing homes our top priority.”
Inpatient / Critical Patient Medical Staff
High-risk facilities such as nursing hospitals, etc.
Priority vaccination of approximately 1 million people
The number of targets for vaccination that quarantine authorities estimate is around 1 million. In addition, priority is given to vaccines older than 65 years, 19-64 years, chronic patients with moderate or greater risk, workers and employees of pediatric and adolescent child care and education centers, Corona 19 first responders, police, firefighters and soldiers . General Manager Jeong said: “We are preparing a plan to finalize vaccinations for those for whom priority vaccination is recommended before the influenza epidemic (November).”
The Korean government has decided to insure a total of 46 million vaccines through multinational partnerships with foreign pharmaceutical companies. AstraZenekawa and AstraZenekawa signed a vaccine contract for a total of 10 million people on the 27th of last month, and on the 23rd of this month they also signed a supply contract with Janssen (for 6 million people) and Pfizer (for 10 million people). people). Modenawa is reviewing a contract to supply 10 million vaccines. It has also signed an agreement with the COVAX facility, an international project for the joint purchase and distribution of vaccines, to supply 10 million people, and is discussing a specific supply schedule.
“The total amount of vaccines for 46 million people purchased by the government, including the planned purchase, represents 88.8% of the total population of 51.8 million people in Korea,” Jung said. “The amount equivalent to 104.3% of the 44.1 million people over 18 years of age who can be vaccinated,” He said. He added: “Taking into account the academic opinion that 60-70% of the total population needs the formation of antibodies for the immunity of the population, this is a sufficient amount for the formation of the immunity of the national population.”
A member of the medical staff of the Croydon Autonomous Region Health Department in South London, UK, is preparing to receive and store the first quantity of a new vaccine against coronavirus infection (Corona 19) jointly developed by Pfizer-Bioentech at Croydon University Hospital. AP = Yonhap News)
Establish a vaccine management system that considers characteristics such as cryogenic distribution and refrigerated storage.
After vaccination, check for abnormal reactions, check for causality, and compensate for status in case of damage.
Corona 19 vaccination is carried out in two ways: by operating a separate vaccination center and by designating a consignment medical institution in consideration of the characteristics of the vaccine type. For vaccines that require an ultra-low temperature distribution of -60 to 90 degrees Celsius, such as Pfizer, about 100 to 250 separate vaccination centers with freezers will be designated and operated. Vaccines that can be stored and distributed in refrigerators such as AstraZeneca and Janssen will be vaccinated by designating an institution that meets the designated criteria among consignment medical institutions with existing vaccination expertise.
Quarantine authorities are also establishing the ‘Corona 19 Vaccination Integrated Management System’ to prevent cross-vaccination of the Corona 19 vaccine, which normally requires two vaccines. In addition to the existing national vaccination system, the supply and management of the vaccine will be carried out here, and the vaccination registry and adverse reactions after vaccination will be monitored.
In addition, for adverse reactions that may occur after vaccination, the joint monitoring system KCDC-Ministry of Food and Drug Safety will be established, and the national compensation system for damages with confirmed causality will be applied.
“We are doing everything possible to introduce vaccines and prepare for safe vaccination. We continue to discuss with individual pharmaceutical companies to speed up the national supply period and secure additional quantities.” I will announce the vaccination plan. “
Reporter Kim Heung-soon [email protected] Reporter Johyun [email protected]
